Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2025 Filed Apr 8, 2025 01:03 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
GrantRestricted Share Units · Derivative | 950,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-010320 · form4-04082025_010445.xml · derivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Ordinary Shares · 950,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| April 03, 2025 Filed Apr 8, 2025 01:04 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
GrantRestricted Share Units · Derivative | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-010321 · form4-04082025_010438.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Ordinary Shares · 90,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| April 03, 2025 Filed Apr 8, 2025 01:02 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-010318 · form4-04082025_010458.xml · derivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:35 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005612 · form4-02262025_010226.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Ordinary Shares · 22,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:35 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 12,116 | $7.30 | $88,446.80 |
DisclosureSEC source: 0001415889-25-005612 · form4-02262025_010226.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,146 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:35 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionOrdinary Shares | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-005612 · form4-02262025_010226.xml · nonDerivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:37 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005616 · form4-02262025_010221.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:37 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Tax withholdingOrdinary Shares | 5,903 | $7.30 | $43,091.90 |
DisclosureSEC source: 0001415889-25-005616 · form4-02262025_010221.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,520 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:37 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionOrdinary Shares | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-005616 · form4-02262025_010221.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:34 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005610 · form4-02262025_010204.xml · derivative · entry 3 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:34 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Tax withholdingOrdinary Shares | 23,500 | $7.30 | $171,550.00 |
DisclosureSEC source: 0001415889-25-005610 · form4-02262025_010204.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 623,291 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:34 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionOrdinary Shares | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-005610 · form4-02262025_010204.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,791 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:32 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005609 · form4-02262025_010236.xml · derivative · entry 5 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Ordinary Shares · 120,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:32 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 63,452 | $7.30 | $463,199.60 |
DisclosureSEC source: 0001415889-25-005609 · form4-02262025_010236.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 906,495 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:32 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 120,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-005609 · form4-02262025_010236.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 969,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:31 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005608 · form4-02262025_010242.xml · derivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Ordinary Shares · 125,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:31 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Tax withholdingOrdinary Shares | 66,095 | $7.30 | $482,493.50 |
DisclosureSEC source: 0001415889-25-005608 · form4-02262025_010242.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,456,483 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:31 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionOrdinary Shares | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-005608 · form4-02262025_010242.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,522,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 02:17 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 24,000 | $6.29 | $150,960.00 |
DisclosureSEC source: 0001415889-25-001828 · form4-01222025_020147.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 849,947 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2024. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $6.14 to $6.39, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:12 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001578 · form4-01162025_110109.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:12 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 2,909 | $5.77 | $16,784.93 |
DisclosureSEC source: 0001415889-25-001578 · form4-01162025_110109.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,762 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:12 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001578 · form4-01162025_110109.xml · nonDerivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:14 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001580 · form4-01162025_110111.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:14 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Tax withholdingOrdinary Shares | 15,149 | $5.77 | $87,409.73 |
DisclosureSEC source: 0001415889-25-001580 · form4-01162025_110111.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,423 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:14 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionOrdinary Shares | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001580 · form4-01162025_110111.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:10 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 23,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001576 · form4-01162025_110124.xml · derivative · entry 3 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 23,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:10 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Tax withholdingOrdinary Shares | 11,163 | $5.77 | $64,410.51 |
DisclosureSEC source: 0001415889-25-001576 · form4-01162025_110124.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 596,791 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:10 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionOrdinary Shares | 23,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001576 · form4-01162025_110124.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 607,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:07 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001575 · form4-01162025_110140.xml · derivative · entry 5 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:07 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 13,219 | $5.77 | $76,273.63 |
DisclosureSEC source: 0001415889-25-001575 · form4-01162025_110140.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 873,947 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:07 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001575 · form4-01162025_110140.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 887,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:05 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001572 · form4-01162025_110114.xml · derivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:05 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Tax withholdingOrdinary Shares | 15,863 | $5.77 | $91,529.51 |
DisclosureSEC source: 0001415889-25-001572 · form4-01162025_110114.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,397,578 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:05 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionOrdinary Shares | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001572 · form4-01162025_110114.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,413,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 08, 2025 Filed Jan 11, 2025 02:07 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
SaleOrdinary Shares | 11,661 | $6.30 | $73,464.30 |
DisclosureSEC source: 0001415889-25-001338 · form4-01112025_020117.xml · nonDerivative · entry 4 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,383,441 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. F7 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F8 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $6.16 to $6.42, inclusive. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:05 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionRestricted Share Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001336 · form4-01112025_020105.xml · derivative · entry 3 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:05 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Tax withholdingOrdinary Shares | 3,966 | $6.34 | $25,144.44 |
DisclosureSEC source: 0001415889-25-001336 · form4-01112025_020105.xml · nonDerivative · entry 2 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,671 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:05 UTC |
Wollin Robert JGENERAL COUNSEL AND SECRETARY
|
Exercise / conversionOrdinary Shares | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001336 · form4-01112025_020105.xml · nonDerivative · entry 1 Wollin Robert J · CIK 0001815161 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:08 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001339 · form4-01112025_020148.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:08 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Tax withholdingOrdinary Shares | 6,886 | $6.34 | $43,657.24 |
DisclosureSEC source: 0001415889-25-001339 · form4-01112025_020148.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,072 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:08 UTC |
Zeldin Robert KCHIEF MEDICAL OFFICER
|
Exercise / conversionOrdinary Shares | 17,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001339 · form4-01112025_020148.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:07 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001338 · form4-01112025_020117.xml · derivative · entry 5 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,500 Underlying: Ordinary Shares · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:07 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
SaleOrdinary Shares | 35,839 | $6.47 | $231,878.33 |
DisclosureSEC source: 0001415889-25-001338 · form4-01112025_020117.xml · nonDerivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,395,102 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. F6 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $6.26 to $6.63, inclusive. F7 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:07 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Tax withholdingOrdinary Shares | 33,048 | $6.34 | $209,524.32 |
DisclosureSEC source: 0001415889-25-001338 · form4-01112025_020117.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,430,941 F4 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:07 UTC |
Forbes AlexandriaDirector · PRESIDENT & CEO
|
Exercise / conversionOrdinary Shares | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001338 · form4-01112025_020117.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,463,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. F3 · balance_after: On August 11, 2024, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person received 28,985 ordinary shares as an annuity payment from a grantor retained annuity trust ("GRAT") and now reports "direct" beneficial ownership of those shares. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:03 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001335 · form4-01112025_020127.xml · derivative · entry 3 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:03 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Tax withholdingOrdinary Shares | 17,625 | $6.34 | $111,742.50 |
DisclosureSEC source: 0001415889-25-001335 · form4-01112025_020127.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 584,204 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:03 UTC |
Naylor StuartCHIEF DEV. OFFICER
|
Exercise / conversionOrdinary Shares | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001335 · form4-01112025_020127.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · CHIEF DEV. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:02 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001334 · form4-01112025_020102.xml · derivative · entry 5 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,500 Underlying: Ordinary Shares · 52,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:02 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 27,760 | $6.34 | $175,998.40 |
DisclosureSEC source: 0001415889-25-001334 · form4-01112025_020102.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 862,166 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.